Zoledronic acid sensitizes breast cancer cells to fulvestrant via ERK/HIF-1 pathway inhibition in�vivoXiaoqing Jia(Fudan University Shanghai Cancer Center), Guang‐Yu Liu(Fudan University Shanghai Cancer Center)Molecular Medicine ReportsJanuary 29, 201810.3892/mmr.2018.8514Cited by 5SaveCiteExport RISWatch citationsRelated PapersBasal and therapy-driven hypoxia-inducible factor-1α confers resistance to endocrine therapy in estrogen receptor-positive breast cancer|Oncotarget|2015|37